Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 2, 2008, Pages 404-409

  Henderson, Mark ^a   McGarry, Ronald ^b   Yiannoutsos, Constantin ^a   Fakiris, Achilles ^a   Hoopes, David ^a   Williams, Mark ^c   Timmerman, Robert ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Non small cell lung cancer; Pulmonary function; Stereotactic body radiotherapy; Toxicity

Indexed keywords

NON-SMALL-CELL LUNG CANCER; PULMONARY FUNCTION; PULMONARY FUNCTIONS; STEREOTACTIC BODY RADIOTHERAPY; TOXICITY;

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC TREATMENT;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD GAS ANALYSIS; CARBON MONOXIDE; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG NEOPLASMS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RADIOSURGERY; SPIROMETRY;

EID: 51449090724     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.12.051     Document Type: Article

References (26)

1. Greene F.L., Page D.L., Fleming I.D., et al. AJCC Cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
2. Harpole Jr. D.H., Herndon II J.E., Young Jr. W.G., et al. Stage I non-small cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 76 (1995) 787-796
3. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
4. Mountain C.F. A new international staging system for lung cancer. Chest 89 Suppl. (1986) 225S-233S
5. Williams D.E., Pairolero P.C., Davis C.S., et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 82 (1981) 70-76
6. McGarry R.C., Song G., des Rosiers P., et al. Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 121 (2002) 1155-1158
7. Gauden S., Ramsay J., and Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108 (1995) 1278-1282
8. Hayakawa K., Mitsuhashi N., Furuta M., et al. High-dose radiation therapy for inoperable non-small cell lung cancer without mediastinal involvement (clinical stage N0, N1). Strahlenther Onkol 172 (1996) 489-495
9. Sibley G.S. Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: Smaller volumes and higher doses-A review. Cancer 82 (1998) 433-438
10. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
11. Fukumoto S., Shirato H., Shimzu S., et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 95 (2002) 1546-1553
12. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
13. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
14. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
15. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
16. Takeda S., Funakoshi Y., Kadota Y., et al. Fall in diffusing capacity associated with induction therapy for lung cancer: A predictor of postoperative complication?. Ann Thorac Surg 82 (2006) 232-236
17. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
18. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
19. Abratt R.P., and Willcox P.A. The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys 31 (1995) 915-919
20. Choi N.C., and Kanarek D.J. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 10 Suppl. 1 (1994) S219-S230
21. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63 (2005) 5-24
22. Sherrill D.L., Enright P.L., Kaltenborn W.T., et al. Predictors of longitudinal change in diffusing capacity over 8 years. Am J Respir Crit Care Med 160 (1999) 1883-1887
23. Viegi G., Sherrill D.L., Carrozzi L., et al. An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern Italy. Chest 120 (2001) 74-80
24. Gopal R., Starkschall G., Tucker S.L., et al. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56 (2003) 114-120
25. Miller K.L., Zhou S.M., Barrier Jr. R.C., et al. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 56 (2003) 611-615
26. Gopal R., Tucker S.L., Komaki R., et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56 (2003) 106-113